Drug
AZD1656 clinical trials
Also written AZD1656.
- studies test it
- 25
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
- AZD1656
- 25
Studies by the year they started
25 studies that test it; most in 2010 (10)
| Year | Studies |
|---|---|
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 10 |
| 2019 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 19
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 23 · Other 2
AstraZeneca (23) · Queen Mary University of London (1) · St George Street Capital (1)
Often tested with
Tested in the same studies.
Simvastatin (1) · Pioglitazone (1) · Sitagliptin (1) · Gemfibrozil (1) · Insulin (1)
Studies
Open first, then newest update. How each study uses AZD1656 is read from its arms, and is right about nine times in ten.
Testing it · 25
- AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNceCompletedPhase 2Queen Mary University of LondonNCT05216172Written as AZD1656
- AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19CompletedPhase 2St George Street CapitalNCT04516759Written as AZD1656
- Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 DiabetesCompletedPhase 2AstraZenecaNCT00856908Written as AZD1656
- Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) PatientsCompletedPhase 2AstraZenecaNCT01020123Written as AZD1656
- Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCompletedPhase 2AstraZenecaNCT00817778Written as AZD1656
- Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus PatientsCompletedPhase 2AstraZenecaNCT01152385Written as AZD1656
- A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) PatientsCompletedPhase 1AstraZenecaNCT01221519Written as AZD1656
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM PatientsCompletedPhase 1AstraZenecaNCT01221545Written as AZD1656
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus PatientsCompletedPhase 1AstraZenecaNCT01103622Written as AZD1656
- To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus PatientsCompletedPhase 1AstraZenecaNCT01069926Written as AZD1656
- A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy VolunteersCompletedPhase 1AstraZenecaNCT00726427Written as AZD1656
- A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy VolunteersCompletedPhase 1AstraZenecaNCT00741689Written as AZD1656
- A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 DiabetesCompletedPhase 1AstraZenecaNCT00747175Written as AZD1656
- To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of InsulinCompletedPhase 1AstraZenecaNCT00768105Written as AZD1656
- Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With SimvastatinCompletedPhase 1AstraZenecaNCT01096940Written as AZD1656
- Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) PatientsCompletedPhase 1AstraZenecaNCT01103609Written as AZD1656
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes MellitusCompletedPhase 1AstraZenecaNCT01082120Written as AZD1656
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes MellitusCompletedPhase 1AstraZenecaNCT01095991Written as AZD1656
- To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656CompletedPhase 1AstraZenecaNCT01083212Written as AZD1656
- Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and SulfonylureaCompletedPhase 1AstraZenecaNCT00995787Written as AZD1656
See all 25 studies that test AZD1656 →
Given in every arm · 1 — AZD1656 is usual care beside what is tested
Codes
What other systems call AZD1656 · ClinicalTrials.gg INT006183
- Wikidata Q27074714AZD1656One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27074714 | AZD1656 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.